Predicting asthma morbidity in children using proposed markers of Th2-type inflammation

Pediatric Allergy and Immunology

Volumn 26, Issue 8, 2015, Pages 772-779

  Konradsen, Jon R ^a,b   Skantz, Elizabeth ^a,b   Nordlund, Björn ^a,b   Lidegran, Marika ^a   James, Anna ^b   Ono, Junya ^c   Ohta, Shoichiro ^d   Izuhara, Kenji ^d   Dahlén, Sven Erik ^b   Alving, Kjell ^e   Hedlin, Gunilla ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SHINO TEST CORPORATION   (Japan)

^d SAGA UNIVERSITY   (Japan)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

Allergy; Asthma; Biomarkers; Children; Eosinophils; Exhaled nitric oxide; IgE; Periostin

Indexed keywords

BIOLOGICAL MARKER; BUDESONIDE; CORTICOSTEROID; IMMUNOGLOBULIN E; NITRIC OXIDE; TRANSCRIPTION FACTOR RUNX2; AUTACOID;

ARTICLE; ASTHMA; BLOOD SAMPLING; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RESPIRATORY TRACT ALLERGY; SCHOOL CHILD; TH2 CELL; ADOLESCENT; ADULT; BLOOD; BREATH ANALYSIS; IMMUNOLOGY; LEUKOCYTE COUNT; LUNG; METABOLISM; RADIOGRAPHY; YOUNG ADULT;

ADOLESCENT; ADULT; ASTHMA; BIOMARKERS; BREATH TESTS; CHILD; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; LUNG; MALE; MORBIDITY; NITRIC OXIDE; TH2 CELLS; YOUNG ADULT;

EID: 84983135265     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12457     Document Type: Article

References (30)

1. Papadopoulos NG, Arakawa H, Carlsen KH, et al. International consensus on (ICON) pediatric asthma. Allergy 2012: 67: 976-97.
2. Hedlin G. Management of severe asthma in childhood - state of the art and novel perspectives. Pediatr Allergy Immunol 2014: 25: 111-21.
3. Smith AD, Cowan JO, Brassett KP, et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med 2005: 172: 453-9.
4. Busse W, Spector S, Rosen K, Wang Y, Alpan O. High eosinophil count: a potential biomarker for assessing successful omalizumab treatment effects. J Allergy Clin Immunol 2013: 132: 485-6.e11.
5. Malinovschi A, Fonseca JA, Jacinto T, Alving K, Janson C. Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects. J Allergy Clin Immunol 2013: 132: 821-7.e1-5.
6. Jia G, Erickson RW, Choy DF, et al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol 2012: 130: 647-54.e10.
7. Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009: 180: 388-95.
8. Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. New England J Med 2011: 365: 1088-98.
9. Hanania NA, Wenzel S, Rosen K, et al. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med 2013: 187: 804-11.
10. Konradsen JR, Nordlund B, Lidegran M, et al. Problematic severe asthma: a proposed approach to identifying children who are severely resistant to therapy. Pediatr Allergy Immunol 2011: 22: 9-18.
11. Lodrup Carlsen KC, Haland G, Devulapalli CS, et al. Asthma in every fifth child in Oslo, Norway: a 10-year follow up of a birth cohort study. Allergy 2006: 61: 454-60.
12. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004: 113: 59-65.
13. Reichenberg K, Broberg AG. Quality of life in childhood asthma: use of the Paediatric Asthma Quality of Life Questionnaire in a Swedish sample of children 7 to 9 years old. Acta Paediatr 2000: 89: 989-95.
14. American Thoracic Society Documents. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005; 171: 912-30.
15. Malmberg LP, Petays T, Haahtela T, et al. Exhaled nitric oxide in healthy nonatopic school-age children: determinants and height-adjusted reference values. Pediatr Pulmonol 2006: 41: 635-42.
16. Polgar G, Weng TR. The functional development of the respiratory system from the period of gestation to adulthood. Am Rev Respir Dis 1979: 120: 625-95.
17. O'Connor G, Sparrow D, Taylor D, Segal M, Weiss S. Analysis of dose-response curves to methacholine. An approach suitable for population studies. Am Rev Respir Dis 1987: 136: 1412-7.
18. Marchac V, Emond S, Mamou-Mani T, et al. Thoracic CT in pediatric patients with difficult-to-treat asthma. AJR Am J Roentgenol 2002: 179: 1245-52.
19. de Blic J, Tillie-Leblond I, Emond S, Mahut B, Dang Duy TL, Scheinmann P. High-resolution computed tomography scan and airway remodeling in children with severe asthma. J Allergy Clin Immunol 2005: 116: 750-4.
20. Okamoto M, Hoshino T, Kitasato Y, et al. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J 2011: 37: 1119-27.
21. Alving KMA. Basic aspects of exhaled nitric oxide. Eur Respir Mon 2010: 49: 1-31.
22. Dweik RA, Sorkness RL, Wenzel S, et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med 2010: 181: 1033-41.
23. Prussin C, Metcalfe DD. 4. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2003: 111: S486-94.
24. Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014: 43: 343-73.
25. Pavord ID, Bafadhel M. Exhaled nitric oxide and blood eosinophilia: independent markers of preventable risk. J Allergy Clin Immunol 2013: 132: 828-9.
26. de Blic J, Scheinmann P. The use of imaging techniques for assessing severe childhood asthma. J Allergy Clin Immunol 2007: 119: 808-10.
27. Bossley CJ, Fleming L, Gupta A, et al. Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines. J Allergy Clin Immunol 2012: 129: 974-82.e13.
28. Wagener AH, de Nijs SB, Lutter R, et al. External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma. Thorax 2015: 70: 115-20.
29. Conway SJ, Izuhara K, Kudo Y, et al. The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci 2014: 71: 1279-88.
30. Inoue Y, Izuhara K, Ohta S, Ono J, Shimojo N. No increase in the serum periostin level is detected in elementary school-age children with allergic diseases. Allergol Int 2015: 64: 289-90.